First elected: 2019
Year of birth: 1953
Ragnar Linder holds a Master of Science in Chemical Engineering from Royal Institute of Technology (KTH). Ragnar is co-founder of Pygargus, a research company in the field of Real World Evidence, which was purchased by IMS Health (now IQVIA) in 2013 and where Ragnar has since held senior positions. Ragnar has also held several senior positions at Amgen Nordic (CEO) Aventis, HMR and Hoechst. Furthermore, Ragnar has been a board member of several biotech pharmaceutical and CRO companies.
Independence: Independent of the Company and the Executive Management and independent of major shareholders.
Other Board Assignments: AlzeCure Pharma AB, 3D Trace AB and Tegnér Biotech Consulting AB.
Holdings: 95 225 shares.